Revenue

Fancamp Exploration is splitting into two companies, creating a stable royalty firm and a high-stakes gold explorer, Goldera, to unlock shareholder value.

DERMAFLASH launches its first sonic dermaplaning system for pros, promising a safer, more effective alternative to traditional scalpel-based treatments.

A new solution promises zero-downtime migration to IBM's MAS, tackling a major hurdle for asset-intensive industries facing a critical support deadline.

Clearwater Paper launches Velora™, a new lightweight paperboard balancing cost, sustainability, and domestic supply to capture the everyday packaging market.

Japanese pharma giant Meiji Seika Pharma backs Centivax's quest for a universal flu vaccine, a move that could revolutionize global pandemic preparedness.

Xplor Technologies and Clubessential merge, forming a $900M global leader with a new CEO and a bold eight-figure investment in artificial intelligence.

Alex Oberberg joins S4 Capital's Monks as EMEA CRO, tasked with scaling AI systems and unifying marketing in a play for regional dominance.

As Houston faces a multi-billion dollar infrastructure crisis, Del Monte Capital's investment in DLG Services signals a new push to fix its aging water systems.

Australian medtech firm 4DMedical lands CE Mark for its revolutionary CT:VQ lung imaging, fueling a major European expansion with a fresh AU$83M investment.

A Georgia firm's painless patch technology earns top honors, promising to revolutionize medicine delivery and solve critical global health challenges.

As 300,000 fans head to Toronto, a discreet safety program expands city-wide to offer a lifeline to those experiencing gender-based violence.

A $15M grant fuels a revolutionary therapy for a fatal childhood disease, turning patients' own cells into 'living biofactories' to fight MPS I.

Boston-based Rockpoint deepens its Sun Belt bet, acquiring a 279,507 sq ft portfolio in Charlotte and Raleigh amid a fierce industrial real estate boom.

The Mediterranean chain is betting on the "swicy" trend, launching a Hot Honey Harissa menu and new fries to challenge fast-casual rivals.

Doble Engineering's new handheld Spark P2 detector promises to revolutionize power grid maintenance with its portability and user-friendly advanced diagnostics.

Amid a tough biotech market, the firm extends its cash runway to 2027, accelerating development of its promising rademikibart treatment for respiratory diseases.

Kekst CNC appoints 20-year veteran Lyndsey Estin as Co-CEO, signaling a strategic focus on AI and cybersecurity in a major leadership shift.

Following rapid growth and a private equity acquisition, DAS Health appoints Lee Horner to navigate healthcare's complex digital and cybersecurity challenges.

Neumora reveals promising data for Alzheimer's and schizophrenia drugs, but a delay in its obesity program highlights the high-stakes world of biotech.

After a major capital overhaul, PAVmed pivots to growth, advancing cancer diagnostics, remote monitoring, and a relaunched device portfolio.